Logo image of CLVT

CLARIVATE PLC (CLVT) Stock Fundamental Analysis

NYSE:CLVT - JE00BJJN4441 - Common Stock

4.35 USD
+0.04 (+0.93%)
Last: 8/29/2025, 8:13:46 PM
4.3701 USD
+0.02 (+0.46%)
After Hours: 8/29/2025, 8:13:46 PM
Fundamental Rating

3

CLVT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. CLVT has a bad profitability rating. Also its financial health evaluation is rather negative. CLVT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CLVT was profitable.
In the past year CLVT had a positive cash flow from operations.
CLVT had negative earnings in each of the past 5 years.
In the past 5 years CLVT always reported a positive cash flow from operatings.
CLVT Yearly Net Income VS EBIT VS OCF VS FCFCLVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

CLVT has a Return On Assets of -3.79%. This is in the lower half of the industry: CLVT underperforms 69.88% of its industry peers.
CLVT has a Return On Equity of -8.68%. This is in the lower half of the industry: CLVT underperforms 69.88% of its industry peers.
CLVT has a worse Return On Invested Capital (1.67%) than 65.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLVT is significantly below the industry average of 12.68%.
Industry RankSector Rank
ROA -3.79%
ROE -8.68%
ROIC 1.67%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
CLVT Yearly ROA, ROE, ROICCLVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

CLVT's Operating Margin of 8.41% is fine compared to the rest of the industry. CLVT outperforms 67.47% of its industry peers.
CLVT's Operating Margin has improved in the last couple of years.
CLVT has a Gross Margin of 66.07%. This is in the better half of the industry: CLVT outperforms 79.52% of its industry peers.
In the last couple of years the Gross Margin of CLVT has remained more or less at the same level.
Industry RankSector Rank
OM 8.41%
PM (TTM) N/A
GM 66.07%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
CLVT Yearly Profit, Operating, Gross MarginsCLVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLVT is destroying value.
Compared to 1 year ago, CLVT has more shares outstanding
CLVT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLVT has a worse debt to assets ratio.
CLVT Yearly Shares OutstandingCLVT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CLVT Yearly Total Debt VS Total AssetsCLVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CLVT has an Altman-Z score of -0.38. This is a bad value and indicates that CLVT is not financially healthy and even has some risk of bankruptcy.
CLVT has a worse Altman-Z score (-0.38) than 80.72% of its industry peers.
The Debt to FCF ratio of CLVT is 13.65, which is on the high side as it means it would take CLVT, 13.65 years of fcf income to pay off all of its debts.
CLVT has a worse Debt to FCF ratio (13.65) than 62.65% of its industry peers.
CLVT has a Debt/Equity ratio of 0.90. This is a neutral value indicating CLVT is somewhat dependend on debt financing.
CLVT's Debt to Equity ratio of 0.90 is on the low side compared to the rest of the industry. CLVT is outperformed by 66.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.65
Altman-Z -0.38
ROIC/WACC0.24
WACC6.99%
CLVT Yearly LT Debt VS Equity VS FCFCLVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.91 indicates that CLVT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.91, CLVT is doing worse than 77.11% of the companies in the same industry.
CLVT has a Quick Ratio of 0.91. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLVT has a Quick ratio of 0.91. This is in the lower half of the industry: CLVT underperforms 77.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
CLVT Yearly Current Assets VS Current LiabilitesCLVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

CLVT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.69%.
CLVT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.87% yearly.
CLVT shows a decrease in Revenue. In the last year, the revenue decreased by -3.92%.
CLVT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.28% yearly.
EPS 1Y (TTM)-7.69%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.44%

3.2 Future

The Earnings Per Share is expected to grow by 0.12% on average over the next years.
CLVT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.76% yearly.
EPS Next Y-9.72%
EPS Next 2Y-2.21%
EPS Next 3Y2.37%
EPS Next 5Y0.12%
Revenue Next Year-6.33%
Revenue Next 2Y-3.28%
Revenue Next 3Y-1.31%
Revenue Next 5Y0.76%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLVT Yearly Revenue VS EstimatesCLVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
CLVT Yearly EPS VS EstimatesCLVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.2 0.4 0.6 0.8

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.04, the valuation of CLVT can be described as very cheap.
CLVT's Price/Earnings ratio is rather cheap when compared to the industry. CLVT is cheaper than 96.39% of the companies in the same industry.
CLVT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.08.
With a Price/Forward Earnings ratio of 6.15, the valuation of CLVT can be described as very cheap.
CLVT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CLVT is cheaper than 95.18% of the companies in the same industry.
CLVT is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.04
Fwd PE 6.15
CLVT Price Earnings VS Forward Price EarningsCLVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLVT is valued cheaply inside the industry as 84.34% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CLVT is valued cheaper than 87.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.83
EV/EBITDA 7.44
CLVT Per share dataCLVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.21%
EPS Next 3Y2.37%

0

5. Dividend

5.1 Amount

CLVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLARIVATE PLC

NYSE:CLVT (8/29/2025, 8:13:46 PM)

After market: 4.3701 +0.02 (+0.46%)

4.35

+0.04 (+0.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners62.11%
Inst Owner ChangeN/A
Ins Owners0.84%
Ins Owner Change11.04%
Market Cap2.92B
Analysts74.67
Price Target5.2 (19.54%)
Short Float %10.93%
Short Ratio7.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.04%
Min EPS beat(2)1.75%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)5.47%
Min EPS beat(4)0.21%
Max EPS beat(4)18.32%
EPS beat(8)7
Avg EPS beat(8)6.13%
EPS beat(12)11
Avg EPS beat(12)8.6%
EPS beat(16)15
Avg EPS beat(16)8.34%
Revenue beat(2)2
Avg Revenue beat(2)2.7%
Min Revenue beat(2)2.04%
Max Revenue beat(2)3.36%
Revenue beat(4)2
Avg Revenue beat(4)-0.24%
Min Revenue beat(4)-4.81%
Max Revenue beat(4)3.36%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.28%
PT rev (1m)-3.43%
PT rev (3m)-3.43%
EPS NQ rev (1m)-1.38%
EPS NQ rev (3m)-6.04%
EPS NY rev (1m)1.14%
EPS NY rev (3m)-0.09%
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)1.29%
Revenue NY rev (3m)1.37%
Valuation
Industry RankSector Rank
PE 6.04
Fwd PE 6.15
P/S 1.17
P/FCF 8.83
P/OCF 4.63
P/B 0.59
P/tB N/A
EV/EBITDA 7.44
EPS(TTM)0.72
EY16.55%
EPS(NY)0.71
Fwd EY16.27%
FCF(TTM)0.49
FCFY11.32%
OCF(TTM)0.94
OCFY21.6%
SpS3.72
BVpS7.43
TBVpS-7.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.79%
ROE -8.68%
ROCE 2.12%
ROIC 1.67%
ROICexc 1.74%
ROICexgc N/A
OM 8.41%
PM (TTM) N/A
GM 66.07%
FCFM 13.24%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
ROICexc(3y)1.93%
ROICexc(5y)1.38%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.36%
ROCE(5y)1.69%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y62.12%
ROICexc growth 5Y45.61%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.65
Debt/EBITDA 4.76
Cap/Depr 40.65%
Cap/Sales 12.02%
Interest Coverage 250
Cash Conversion 66.51%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z -0.38
F-Score6
WACC6.99%
ROIC/WACC0.24
Cap/Depr(3y)37.07%
Cap/Depr(5y)34.15%
Cap/Sales(3y)10.18%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.69%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y-9.72%
EPS Next 2Y-2.21%
EPS Next 3Y2.37%
EPS Next 5Y0.12%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.44%
Revenue Next Year-6.33%
Revenue Next 2Y-3.28%
Revenue Next 3Y-1.31%
Revenue Next 5Y0.76%
EBIT growth 1Y-19.21%
EBIT growth 3Y32.53%
EBIT growth 5Y83.55%
EBIT Next Year9479.49%
EBIT Next 3Y362.47%
EBIT Next 5Y154.38%
FCF growth 1Y-31.45%
FCF growth 3Y16.61%
FCF growth 5Y48.48%
OCF growth 1Y-14.01%
OCF growth 3Y25.93%
OCF growth 5Y40.62%